USSTOCK.TODAY
After-Market
Log in Sign up

Labcorp and Quest Diagnostics Urge Passage of RESULTS Act

MedTech Dive · ·by G4L

DGX Quest Diagnostics Inc
$258.69 +0.10%
View chart & analysis →
  1. 1Labcorp and Quest Diagnostics are pressuring Congress to pass the RESULTS Act before the end of the year.
  2. 2Reimbursements for 775 tests are expected to decrease by 15% in 2027.
  3. 3Labcorp faces an estimated $125,000,000 impact due to decreased government reimbursements in 2027.

So what's the key point?

Labcorp and Quest Diagnostics are calling for the passage of a bill. Labcorp could see a $125,000,000 reduction in government payments in 2027.

Source MedTech Dive · View original ↗

Related 3-line summaries

Siemens Healthineers to Rebrand and Transition In Vitro Diagnostics Division into Independent Organization MedTech Dive · 4d agoQuest Diagnostics Reports Revenue Growth and Raises Annual Guidance The Motley Fool +2 · Oct 23Quest Diagnostics reports patient record leak due to unauthorized system access Reuters · Oct 22
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news